Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data. - Wikidata - awgldk - TriplyDB

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data.

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data.

http://www.wikidata.org/entity/Q31125799

about

Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis.

P2860

Q33651541-027667B2-3E25-4743-B571-A59B7EA3ED6C

P2860

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data.

http://www.wikidata.org/entity/Q31125799

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Fondaparinux versus Enoxaparin ...... me? - Brazilian Registry Data.

@ast

Fondaparinux versus Enoxaparin ...... me? - Brazilian Registry Data.

@en

type

label

Fondaparinux versus Enoxaparin ...... me? - Brazilian Registry Data.

@ast

Fondaparinux versus Enoxaparin ...... me? - Brazilian Registry Data.

@en

prefLabel

Fondaparinux versus Enoxaparin ...... me? - Brazilian Registry Data.

@ast

Fondaparinux versus Enoxaparin ...... me? - Brazilian Registry Data.

@en

P1433

Q31125799-8A39BC47-2805-414A-BB73-C7DD2564134A

P1476

Q31125799-425BC702-7923-4C7D-BCB3-1FD68B3B65C8

P2093

Q31125799-0CC4B946-F5C9-4055-98D6-68CB596A8E5A

Q31125799-2D21C89C-D98A-4F15-BA7B-4EA31A0453F6

Q31125799-3B8DA5C6-F836-4177-A9E7-6B364D1175CC

Q31125799-567CBA0A-056E-4981-BC04-4F67A1E338B9

Q31125799-5A294F38-B67F-462F-B738-57A8E6CF2BA3

Q31125799-5D6A2103-DDC3-44E5-ADF1-31FEA3556D9B

Q31125799-75A88F8C-2283-456F-97F8-0F84A73CBE67

Q31125799-9A19B108-09E8-4CCA-8889-81E11436154E

Q31125799-CB267A57-DF81-4D9F-BC8F-ECBF966486C7

Q31125799-D10FCFF2-B035-4C78-A157-8037B70455EC

P2860

Q31125799-0A279982-A8D0-48E6-9043-6EAD744CD9AB

Q31125799-1102779D-F4AD-4F70-9ECE-9C3BFC885B9A

Q31125799-20DA32D1-0F86-4CCC-9F12-BA7E79D0316C

Q31125799-25F96F87-8106-49C5-9822-FCDA86140CED

Q31125799-3D8A0529-335F-4EC8-B388-4F22EAD214D4

Q31125799-4225D9F0-F87C-44DA-92F3-321CEFDEBEB3

Q31125799-4EA09F8D-5BFB-4EB0-972A-11CFFD4D6A99

Q31125799-52C601F0-7A37-488F-8A70-3B5BA4430B3A

Q31125799-5586D1AE-CF9A-48F3-9966-9867EBA98460

Q31125799-6DDD570F-964E-40FC-B7DD-C8196AD144BC

P304

Q31125799-8FF431AF-D970-4747-9E45-695B71EE32EB

P31

Q31125799-1547CA16-EC3D-4884-B423-2E2F52F0BD20

P356

Q31125799-3800CA75-EEC7-44C4-90CE-947E1EE8E72E

P433

Q31125799-57CF2088-D9FC-45A1-8487-2CA2E066F8A2

P478

Q31125799-E2EA7B53-6265-43BB-8A4A-69E6F40E6FDB

P577

Q31125799-AF7336F5-EF7C-4873-9A44-368068DBEB15

P698

Q31125799-06F8A0E4-A7DE-480B-A5D6-5A4B9CA3B6CF

P921

Q31125799-FBEB760D-21B9-49F0-8161-EEE3E8C4CFD2

P932

Q31125799-ABEC5834-4F35-4EAE-9433-BA91A7BC83A6

P356

P1433

Arquivos Brasileiros De Cardiologia

P1476

Fondaparinux versus Enoxaparin ...... me? - Brazilian Registry Data.

@en

P2093

Alexandre de Matos Soeiro

http://www.w3.org/2001/XMLSchema#string

Aline Siqueira Bossa

http://www.w3.org/2001/XMLSchema#string

Eduardo Alberto de Castro Roque

http://www.w3.org/2001/XMLSchema#string

Fátima Cristina Monteiro Pedroti

http://www.w3.org/2001/XMLSchema#string

Maria Cristina César

http://www.w3.org/2001/XMLSchema#string

Mariana Yumi Okada

http://www.w3.org/2001/XMLSchema#string

Múcio Tavares de Oliveira

http://www.w3.org/2001/XMLSchema#string

Pedro Gabriel Melo de Barros E Silva

http://www.w3.org/2001/XMLSchema#string

Sheila Aparecida Simões

http://www.w3.org/2001/XMLSchema#string

Tatiana de Carvalho Andreucci Torres Leal

http://www.w3.org/2001/XMLSchema#string

P2860

Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol

A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5).

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.

Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand.

P304

239-244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5935/ABC.20160127

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27579543

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5053192

http://www.w3.org/2001/XMLSchema#string